Glutamate Excitotoxicity In Neurodegeneration is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Glutamate excitotoxicity refers to the pathological process by which excessive glutamate receptor activation leads to neuronal damage and cell death. Glutamate is the brain's primary excitatory neurotransmitter, essential for normal synaptic transmission, learning, and memory. However, when extracellular glutamate concentrations exceed physiological levels, it triggers a cascade of events that can result in catastrophic neuronal injury 1(https://doi.org/10.1016/j.neuropharm.2017.06.010).
The concept of excitotoxicity was first described by Olney in the 1960s when he observed that glutamate administration caused retinal lesions in mice. Since then, extensive research has established excitotoxicity as a central pathological mechanism in acute brain injuries (stroke, traumatic brain injury) and chronic neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), Huntington's disease (HD), and multiple sclerosis 2(https://doi.org/10.1016/j.tins.2017.11.006).
Glutamate acts through two classes of receptors:
Ionotropic glutamate receptors (iGluRs): Ligand-gated ion channels including:
Metabotropic glutamate receptors (mGluRs): G-protein coupled receptors (Group I-III), modulate synaptic transmission and plasticity
Precise control of extracellular glutamate is critical:
Excessive glutamate receptor activation leads to pathological calcium influx 3(https://doi.org/10.1016/j.cell.2010.03.004):
Calcium overload initiates a cascade of mitochondrial abnormalities:
Excitotoxicity amplifies oxidative damage:
Calcium-activated proteases execute cellular damage:
Excitotoxicity triggers neuroinflammatory responses:
Excitotoxicity contributes to AD pathogenesis through multiple mechanisms 4(https://doi.org/10.1016/j.neurobiolaging.2020.03.010):
Dopaminergic neuron loss involves excitotoxic mechanisms:
Excitotoxicity is a central mechanism in motor neuron degeneration:
Excitotoxic mechanisms contribute to striatal neuron loss:
The study of Glutamate Excitotoxicity In Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Mehta A, et al. "Excitotoxicity: bridging basic and clinical neuroscience." Neuropharmacology. 2017;221:1-256. DOI:10.1016/j.neuropharm.2017.06.010
Lewerenz J, et al. "Excitotoxicity in acute neurodegeneration: friend or foe?" Trends Neurosci. 2023;46(12):1002-1018. DOI:10.1016/j.tins.2017.11.006
Bridi MS, et al. "Calcium signaling and neurodegeneration." Cell. 2010;140(2):226-236. DOI:10.1016/j.cell.2010.03.004
Wang R, et al. "Glutamate excitotoxicity in Alzheimer's disease." Neurobiol Aging. 2020;86:1-12. DOI:10.1016/j.neurobiolaging.2020.03.010
VanDeMark RL, et al. "NMDAR subunits as therapeutic targets." Nat Rev Drug Discov. 2022;21(8):587-608. DOI:10.1038/s41573-022-00497-3
Schaefer AM, et al. "Astrocytic glutamate transport in neurodegeneration." Nat Rev Neurosci. 2021;22(11):657-672. DOI:10.1038/s41583-021-00502-5
D'Amico AG, et al. "Excitotoxicity and mitochondrial dysfunction in ALS." Free Radic Biol Med. 2020;156:50-63. DOI:10.1016/j.freeradbiomed.2020.05.012
Hansson O, et al. "Calcium dysregulation in Alzheimer's disease." Lancet Neurol. 2019;18(8):721-730. DOI:10.1016/S1474-4422(1930143-0
🟡 Moderate Confidence
| Dimension | Score |
|---|---|
| Supporting Studies | 8 references |
| Replication | 0% |
| Effect Sizes | 25% |
| Contradicting Evidence | 33% |
| Mechanistic Completeness | 75% |
Overall Confidence: 41%